This episode of Chromatography Life takes a closer look at the evolving landscape of synthetic peptide drugs - one of the most compelling frontiers in biopharmaceutical analysis. Joining us is Matt Lauber, Senior Director at Waters and a recognized authority in bioanalysis and drug product characterization, who shares both his personal and professional journey, along with his insights into the science shaping today’s peptide therapeutics. We discuss the growing significance of GLP-1 peptide drugs, the analytical hurdles they present, and the chromatographic techniques that help ensure their safety and effectiveness. Whether you're already immersed in the world of drug development or just peptide-curious, this conversation provides the right dose of thoughtful perspective on how innovation and precision change are changing the future of human health.

Join host Neil Lander on Chromatography Life as he interviews, Arnaud Delobel, R&D and Innovation Director at Quality Assistance. In this episode, Arnaud discusses chromatographic analysis for new modalities, with adeno-associated viruses (AAVs) in the spotlight. He discusses the complexities of analyzing these large biomolecules and the innovative techniques being developed to improve their characterization. Tune in to glimpse the future of chromatography and learn about the incredible advancements that are helping to tackle some of the toughest human health challenges.

Join host Neil Lander on Chromatography Life as he interviews Ben Calvopina, Application Scientist and expert in dissolution testing at SOTAX. Ben shares his journey from service engineering to leading automation projects, highlighting the impact of automation on efficiency and accuracy in pharmaceutical quality control. The episode explores the practical aspects of automating dissolution methods and the importance of validation to ensure reliable results. Tune in to this episode to learn about the latest trends and future directions in chromatography and dissolution.